A 28-year-old woman with generalized tonic-clonic seizures is counselled about antiepileptic choice. She is planning pregnancy in 6 months. Which feature best distinguishes lamotrigine from levetiracetam in the context of pregnancy and teratogenicity?

Explanation

## Pregnancy and Teratogenicity: Lamotrigine vs. Levetiracetam ### Lamotrigine in Pregnancy **Key Point:** Lamotrigine undergoes **glucuronidation**, which is dramatically increased during pregnancy (up to 2-fold clearance increase), requiring **dose escalation to maintain seizure control**. - Mechanism: Pregnancy increases UGT enzyme activity - Clinical consequence: Lamotrigine levels drop significantly; seizure breakthrough risk is high if dose not increased - Teratogenic risk: **Relatively LOW** compared to older agents (phenytoin, valproate) - SJS risk: Present (though rare) — requires monitoring ### Levetiracetam in Pregnancy **Key Point:** Levetiracetam is **renally excreted unchanged** and is **NOT metabolized by hepatic enzymes**. Pregnancy does NOT significantly alter its clearance. - Mechanism: Minimal placental transfer; renal clearance unchanged - Clinical consequence: **NO dose adjustment typically needed** during pregnancy - Teratogenic risk: **Very low** — limited human data, but animal studies reassuring - SJS risk: Absent (not associated with severe cutaneous reactions) ## Comparison Table | Feature | Lamotrigine | Levetiracetam | | --- | --- | --- | | **Metabolism** | Hepatic glucuronidation (UGT) | Renal excretion (unchanged) | | **Pregnancy Effect on Clearance** | **↑ 2-fold** (requires dose ↑) | **Minimal change** (no adjustment) | | **Teratogenic Risk** | Low (but higher than LEV) | Very low | | **SJS/TEN Risk** | Yes (rare but notable) | No | | **Spectrum** | Partial, generalized, bipolar | Broad-spectrum | ## Clinical Pearl **Clinical Pearl:** Levetiracetam is increasingly preferred in **women of childbearing potential** because: 1. No dose adjustment during pregnancy 2. Minimal placental transfer 3. No enzyme induction/inhibition (no drug interactions) 4. No teratogenic signal **High-Yield:** The **dose escalation requirement during pregnancy** is the key discriminator. Lamotrigine levels fall; LEV levels remain stable. This is a frequent NEET PG question. **Mnemonic:** **LAMO = Levels drop, Adjust Maintenance, Observe closely** (during pregnancy). **LEV = Levels Essentially Stable, Virtually no adjustment needed**. **Warning:** Do NOT assume lamotrigine is contraindicated in pregnancy — it is used when appropriate, but requires active dose management. Levetiracetam requires NO such adjustment.